Cargando…

Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2

Mostrar otras versiones (1)

OBJECTIVE: To determine the impact of acute SARS-CoV-2 infection on patient with concomitant active cancer and CVD. METHODS: The researchers extracted and analyzed data from the National COVID Cohort Collaborative (N3C) database between January 1, 2020, and July 22, 2022. They included only patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Brijesh, Chapman, Scott, Neumann, Jake, Visaria, Aayush, Ogungbe, Oluwabunmi, Wen, Sijin, Khodaverdi, Maryam, Makwana, Priyal, Singh, Jasvinder A., Sokos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246256/ https://www.ncbi.nlm.nih.gov/pubmed/37292998 http://dx.doi.org/10.21203/rs.3.rs-2952641/v1

Ejemplares similares

Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023)

COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022)

HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022)

TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS
por: Visaria, Aayush, et al.
Publicado: (2022)

CARDIOVASCULAR PATIENT OUTCOMES AND COMPLICATIONS AFTER SARS-COV-2 INFECTION
por: Khodaverdi, M., et al.
Publicado: (2022)

HEALTH DISPARITIES INVOLVING HOSPITALIZATIONS AMONG COVID-19 VACCINATED CARDIOVASCULAR DISEASE PATIENTS INFECTED BY SARS-COV-2
por: Khodaverdi, M., et al.
Publicado: (2022)

Exploring Unconventional Risk-Factors for Cardiovascular Diseases: Has Opioid Therapy Been Overlooked?
por: Ogungbe, Oluwabunmi, et al.
Publicado: (2019)

Sewage Pollution in Water Supply in Indore
por: Tahir, Alifiya, et al.
Publicado: (2017)

Association between body mass index and hypertension subtypes in Indian and United States adults
por: Visaria, Aayush, et al.
Publicado: (2020)

SAT-623 Glucose Intolerance Modifies the Association Between Insulin-Like Growth Factor-1 and All-Cause Mortality
por: Visaria, Aayush, et al.
Publicado: (2020)

Necessary complexities when standardizing hypertension protocols in India
por: Visaria, Aayush, et al.
Publicado: (2020)

The complex causes of India's 2021 COVID-19 surge
por: Visaria, Aayush, et al.
Publicado: (2021)

Body mass index and all-cause mortality in a 21(st) century U.S. population: A National Health Interview Survey analysis
por: Visaria, Aayush, et al.
Publicado: (2023)

Recruitment of Black Adults into Cardiovascular Disease Trials
por: Prasanna, Anagha, et al.
Publicado: (2021)

Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib
por: Avalon, Juan Carlo, et al.
Publicado: (2021)

Important considerations when assessing the effect of essential fatty acids on cognitive performance
por: Visaria, Aayush, et al.
Publicado: (2020)

Generalizability of hypertension risk factors and achieving blood pressure control in educator populations in India
por: Visaria, Aayush, et al.
Publicado: (2021)

Observations and hypotheses for potential generational differences in cardiometabolic risk factors in U.S. South Asians
por: Parikh, Trishna, et al.
Publicado: (2021)

OR10-01 Discordance Between Body Mass Index and Dual-energy X-ray Absorptiometry Based Adiposity Measures Among United States Adults
por: Visaria, Aayush, et al.
Publicado: (2023)

Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study
por: Visaria, Aayush, et al.
Publicado: (2020)

Hypertension among Mississippi Workers by Sociodemographic Characteristics and Occupation, Behavioral Risk Factor Surveillance System
por: Mendy, Vincent L., et al.
Publicado: (2020)

Medication Adherence Interventions for Cardiovascular Disease in Low- and Middle-Income Countries: A Systematic Review
por: Ogungbe, Oluwabunmi, et al.
Publicado: (2021)

Retrospective cohort study investigating synergism of air pollution and corticosteroid exposure in promoting cardiovascular and thromboembolic events in older adults
por: Josey, Kevin, et al.
Publicado: (2023)

Association of HCV Infection with C-Reactive Protein: National Health and Nutrition Examination Survey (NHANES), 2009–2010
por: Bhuiyan, Azad R., et al.
Publicado: (2019)

COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension
por: Chakinala, Raja Chandra, et al.
Publicado: (2021)

Maximizing the potential of the Salt Substitute in India Study
por: Visaria, Aayush, et al.
Publicado: (2020)

Leg and arm adiposity is inversely associated with diastolic hypertension in young and middle-aged United States adults
por: Visaria, Aayush, et al.
Publicado: (2022)

Pre-existing and machine learning-based models for cardiovascular risk prediction
por: Cho, Sang-Yeong, et al.
Publicado: (2021)

Cardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults: cross-sectional study
por: Ogungbe, Oluwabunmi, et al.
Publicado: (2022)

Disparities in Hepatitis B Vaccine Coverage by Race/Ethnicity: The National Health and Nutrition Examination Survey (NHANES) 2015–2016
por: Bhuiyan, Azad R., et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on HIV Healthcare Service Engagement, Treatment Adherence, and Viral Suppression in the United States: A Systematic Literature Review
por: Meyer, Diane, et al.
Publicado: (2022)

Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease
por: Kerolos, Mina Medhat, et al.
Publicado: (2022)

Racial/Ethnic Differences in Leisure-Time Physical Activity Among United States Adults With and Without Diabetes
por: Visaria, Aayush, et al.
Publicado: (2021)

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia
por: Lee, Eun-Ju, et al.
Publicado: (2021)

Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?
por: Mansueto, Gelsomina, et al.
Publicado: (2020)

Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19
por: O’Gallagher, Kevin, et al.
Publicado: (2021)

Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19
por: Sritharan, Hari P., et al.
Publicado: (2023)

Heterogeneity in Cardiovascular Disease Risk Factor Prevalence Among White, African American, African Immigrant, and Afro‐Caribbean Adults: Insights From the 2010–2018 National Health Interview Survey
por: Baptiste, Diana‐Lyn, et al.
Publicado: (2022)

Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
por: Parhiz, Hamideh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pr3h078cc0tjgmj9bar3vqlinu